MODERATOR
:
SPEAKER
(S):
Anthony Lee-Kin, PMP, Director, Information System Quality, Blood Systems, Inc.
John Hoffman, Managing Director, QMR, LLC
FDA's Medical Device Data Systems Regulation, MDDS - The Blood Center Prospective
Rob Hyatt, Director, Clinical Systems QA/RA, Intermountain Healthcare
MDDS - The Hospital Prospective
Description
FDAs Medical Device Data Systems (MDDS) regulation affects healthcare organizations that create or modify an MDDS. They become classified as a medical device manufacturer under the regulation and are subject to the device regulations. This session will provide organizations guidance to determine if they are creating or modifying an MDDS. Both the hospital and blood center prospective will be presented, and the speakers will discuss the responsibilities required for the organizations quality system to manage their MDDS responsibilities.
-
Determine if an organization is responsible for compliance with the MDDS regulation.
-
Explain the FDA MDDS regulation.
-
Identify the organizational responsibilities for managing an MDDS.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.